We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases.
GeneRide is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies
With GeneRide, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.